The Corner Booth

 The invention of a "noninvasive" device that can measure blood glucose for people with diabetes with no need to poke the skin and draw blood has been the dream for decades. After all, why wouldn't people with diabetes (PWDs) flock to a skin patch that can detect blood sugar levels through sweat, or a wrist band that uses radio frequency technology to continuously beam glucose data directly to an app? Numerous companies are pushing forward in this noninvasive continuous glucose monitoring (CGM) space, even in the midst of a pandemic. To date, it's been mostly hype versus hope, as attempts to create those products have fallen flat. The Diabetes Technology Society (DTS) published a scientific analysis on this topic in October 2021, noting "the amount of interest in seeing the development of an accurate [noninvasive glucose sensor] and the amount of hyperbole by companies promising an accurate [product] both far outstrip the amount of publicly avai...

As we look to what's ahead in new diabetes technology for 2022, many may experience a sense of déjà vu. After all, much of what we'd anticipated for 2021 was delayed because of the continuing global pandemic (much like the year before). That means a lot of the forecast for the year ahead resembles what had initially been on tap a year earlier. Still, it's exciting to look at new innovations anticipated to literally change the face of daily diabetes management — from new insulin pens and pumps, to CGMs, and smart closed loop tech, or Automated Insulin Delivery (AID) systems. Our DiabetesMine team has been listening to industry earnings calls, and talking with company insiders and other experts to compile this roundup of what’s expected to materialize in 2022, with some of our own insights and observations sprinkled in. Tandem Diabetes Care For the first time, people with diabetes (PWDs) will likely see technology giving us the ability to control our medical ...